Healthcare Innovation December 15, 2022
David Raths

Rule would also establish a health equity index in the Star Ratings program that would reward excellent care for underserved populations by Medicare Advantage and Medicare Part D plans

The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule to strengthen Medicare Advantage and Medicare Part D prescription drug coverage and prior authorization rules. The rule also proposes changes focused on misleading marketing, behavioral health and health equity.

“We are taking feedback from thousands of Americans and turning it into concrete action to strengthen Medicare for the millions of Americans who rely on it,” said HHS Secretary Xavier Becerra, in a statement. “From streamlining prior authorization to cracking down on misleading marketing, we are committed to ensuring...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Provider
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
HHS: Ozempic, Wegovy will be part of Medicare Part D drug price negotiations this year
CMS says record 24.2 million enrolled in Marketplace coverage for 2025

Share This Article